Your browser doesn't support javascript.
loading
Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria.
Gilson, Paul R; Nguyen, William; Poole, William A; Teixeira, Jose E; Thompson, Jennifer K; Guo, Kaiyuan; Stewart, Rebecca J; Ashton, Trent D; White, Karen L; Sanz, Laura M; Gamo, Francisco-Javier; Charman, Susan A; Wittlin, Sergio; Duffy, James; Tonkin, Christopher J; Tham, Wai-Hong; Crabb, Brendan S; Cooke, Brian M; Huston, Christopher D; Cowman, Alan F; Sleebs, Brad E.
Afiliação
  • Gilson PR; Burnet Institute, Melbourne, Victoria, Australia.
  • Nguyen W; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Victoria, Australia.
  • Poole WA; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Teixeira JE; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Thompson JK; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Victoria, Australia.
  • Guo K; Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USA.
  • Stewart RJ; Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA.
  • Ashton TD; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • White KL; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Sanz LM; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Gamo FJ; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Charman SA; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Wittlin S; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Duffy J; Centre for Drug Candidate Optimisation, Monash University, Parkville, Melbourne, Victoria, Australia.
  • Tonkin CJ; Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain.
  • Tham WH; Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain.
  • Crabb BS; Centre for Drug Candidate Optimisation, Monash University, Parkville, Melbourne, Victoria, Australia.
  • Cooke BM; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Huston CD; University of Basel, Basel, Switzerland.
  • Cowman AF; Medicines for Malaria Venture, ICC, Geneva, Switzerland.
  • Sleebs BE; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Antimicrob Agents Chemother ; 63(3)2019 03.
Article em En | MEDLINE | ID: mdl-30559138
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Quinazolinas / Toxoplasma / Cryptosporidium parvum / Babesia bovis / Compostos de Anilina / Antiparasitários Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Quinazolinas / Toxoplasma / Cryptosporidium parvum / Babesia bovis / Compostos de Anilina / Antiparasitários Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália